T0	SampleSize 18896 18917	sample size was small
T1	UnderpoweredStudy 21416 21490	This study was not powered to evaluate efficacy endpoints of rosiglitazone
T2	VerySpecificPopulation 21501 21654	the outcomes of the uncomplicated malaria participants recruited to evaluate the safety and tolerability of the drug, may not be sufficiently informative
T3	MissingData 22087 22180	limited pharmacokineticâ€“pharmacodynamic data of rosiglitazone in children under the age of 10
T4	VerySpecificPopulation 18173 18273	it cannot be assumed that a similar safety profile would be observed in children with severe malaria
